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Abstract: The use of radiofrequency devices has become widespread for surgical ablation procedures. When ablation 
devices have been deployed in treatment settings requiring tissue preservation like débridement chondroplasty, adoption 
has been limited due to the collateral damage caused by these devices in healthy tissue surrounding the treatment site. Ex 
vivo  radiofrequency mediated débridement chondroplasty was performed on osteochondral specimens demonstrating 
surface fibrillation obtained from patients undergoing knee total joint replacement. Three radiofrequency systems 
designed to perform débridement chondroplasty were tested each demonstrating different energy delivery methods: 
monopolar ablation, bipolar ablation, and non-ablation energy. Treatment outcomes were compared with control 
specimens as to clinical endpoint and histopomorphic characteristics. Fibrillated cartilage was removed in all specimens; 
however, the residual tissue remaining at the treatment site displayed significantly different characteristics attributable to 
radiofrequency energy delivery method. Systems that delivered ablation-based energies caused tissue necrosis and 
collateral damage at the treatment site including corruption of cartilage Superficial and Transitional Zones; whereas, the 
non-ablation system created a smooth articular surface with Superficial Zone maintenance and without chondrocyte death 
or tissue necrosis. The mechanism of radiofrequency energy deposition upon tissues is particularly important in treatment 
settings requiring tissue preservation. Ablation-based device systems can cause a worsened state of articular cartilage 
from that of pre-treatment. Non-ablation energy can be successful in modifying/preconditioning tissue during débridement 
chondroplasty without causing collateral damage. Utilizing a non-ablation radiofrequency system provides the ability to 
perform successful débridement chondroplasty without causing additional articular cartilage tissue damage and may allow 
for other cartilage intervention success. 
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INTRODUCTION 
  Débridement chondroplasty serves a large clinical need 
and disease burden afflicting our population [1-5]. The goal 
is to remove the damaged cartilage that causes a mechanical 
and inflammatory impairment of joint function and leads to a 
deterioration of joint health. Smoothing the articular surface 
can eliminate the mechanical stress-risers that cause 
symptoms and propagate cartilage damage; removal of the 
loose surface debris associated with loss of cartilage function 
decreases the biologic load the joint needs to address. During 
such treatment, preserving functioning cartilage tissue is 
important because in situ chondrocytes have shown low 
expectant tissue regenerative potential at the site of injury 
and disease. Undesirably, all current débridement 
chondroplasty techniques induce necrosis and collateral 
damage to contiguous untargeted cartilage tissue at the 
treatment site. 
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  Mechanical motorized shavers have been the traditional 
treatment standard for débridement chondroplasty [6]; 
however, ablation-based radiofrequency devices are 
becoming increasingly more popular [7], either alone or in 
combination with mechanical motorized shavers [8]. When 
used correctly, ablation-based radiofrequency devices offer 
more precise tissue débridement, limiting the extent of 
collateral tissue damage while accomplishing cartilage 
procedures deemed beneficial to the patient [7-10]. Studies 
have shown that débridement chondroplasty with ablation-
based radiofrequency devices causes less collateral damage 
and creates a smoother articular surface than mechanical 
motorized shavers [8, 11-15]. Despite these advantages, the 
adoption of ablation-based radiofrequency mediated 
débridement chondroplasty remains limited as many 
practitioners are uncomfortable causing iatrogenic collateral 
damage to articular cartilage. Accordingly, some have even 
retreated from using mechanical motorized shavers for 
articular cartilage lesions other than large symptomatic 
chondral flaps. 
  The advent of ablation-based radiofrequency mediated 
débridement chondroplasty has brought the issue of 
iatrogenic collateral damage to a forefront of cartilage   
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research. The mechanism of action of ablation-based 
radiofrequency treatments is to induce therapeutic tissue 
necrosis through electrode-to-tissue contact. In many 
ablation treatment settings, the tissue type or treatment 
location tolerates imprecise tissue necrosis and collateral 
damage as accepted sequelae of the surgical procedure. Yet 
when applied to treatment sites where tissue preservation is 
important, such as articular cartilage, researchers have 
echoed the concern of practitioners as to whether such 
iatrogenic tissue necrosis and resultant collateral damage are 
counterproductive to treatment goals [16-22]. Concerns such 
as whether ablation-induced tissue necrosis delays or impairs 
residual cellular function [9, 10, 17, 23, 24], alters cartilage 
mechanical characteristics and permeability properties [15, 
23], disrupts the function of the proteoglycan-collagen 
matrix [15, 23], extends cartilage injury [19, 21, 22], or 
accelerates the natural progression of disease [15, 18, 20] 
continue to be raised despite the lack of other more effective 
treatment options to offer patients. 
  Because of these circumstances, articular cartilage has 
become a good model to evaluate tissue preservation 
techniques due to the susceptibility of chondrocytes to 
perturbation and the tissue's sensitivity to collateral damage 
from mechanical, thermal, metabolic, and other disturbances. 
It is clear that before radiofrequency devices can become 
more widely accepted for tissue preservation treatments, 
such as débridement chondroplasty, further control 
mechanisms for the delivery and deposition of 
radiofrequency energy to tissue are required. Since ablation-
based radiofrequency devices leave behind a residual layer 
of necrotic tissue at the treatment site, their use may not be 
appropriate in tissue preservation settings exhibiting little 
repair and regeneration potential such as articular cartilage. 
  Recently, non-ablative radiofrequency systems have been 
developed that deliver a low-level of energy to the treatment 
site through a protected tip architecture inhibiting electrode-
to-tissue contact. The goal of these systems is to deliver non-
necrosis-based treatments that maximize tissue preservation 
while achieving desirable clinical outcomes. The design 
allows, for example, the combination of controlled low-level 
radiofrequency energy delivery with a gentle non-motorized 
and non-electrical-based mechanical treatment feature of the 
protective housing rather than within the active electrode 
itself as in ablation-based devices. These newer radio-
frequency energy systems do not ablate tissue, but instead 
modify or precondition tissue toward a state amenable for 
other treatments, such as, in this case, the débridement of 
damaged articular cartilage. 
  The purpose of this study is to evaluate the histopo-
morphic outcome of radiofrequency device use in a clinical 
treatment setting that requires tissue preservation based upon 
the method of energy delivery and deposition. Three 
methods are studied, all of which have been designed for 
débridement chondroplasty by their manufacturers, including 
a monopolar ablation-based system, a bipolar ablation-based 
system, and a non-ablation system. Even though ablation-
based radiofrequency systems have been shown to be more 
precise than traditional mechanical motorized shavers, it 
remains unclear whether débridement chondroplasty can be 
an effective tissue preservation procedure through the use of 
newer non-ablative interventions. 
MATERIALS AND METHODOLOGY 
  Osteochondral specimens were harvested from patients 
undergoing total knee replacement under an approved 
Institutional Review Board protocol. The total knee 
replacement procedures were performed by a single surgeon 
in the normal course of his practice. The tissue to be 
normally discarded during the procedure was examined prior 
to harvest once the knee joint was entered surgically to 
determine if it met the requirement for study inclusion. 
Specimens were included that demonstrated an area of 
uniform surface fibrillation chondromalacia (partial 
thickness damage) of sufficient size from which four test 
samples could be obtained from each specimen, each 
demonstrating geographically similar characteristics. After 
harvest, specimens were divided into four parts [25] as 
depicted in Fig. (1). Each part was randomly sequestered 
into a treatment group and immediately transferred to an ex 
vivo saline arthroscopic treatment setting. Four treatment 
groups were established, consisting of one for each 
radiofrequency system tested and a control. 
 
Fig. (1). Diagrammatic representation of the specimen division and 
treatment locations within each segmented part. Specimens were 
sectioned such that four test samples were obtained, each 
demonstrating geographically similar characteristics. The treatment 
sites were away from the sectioned edges but within the uniform 
surface fibrillation area to avoid edge artifact. 
  Three radiofrequency systems designed for débridement 
chondroplasty were studied each utilizing a different method 
of energy delivery and deposition to tissue. All systems were 
used per manufacturer's specifications and are characterized 
in Table 1. They include: Glider
® (Smith and Nephew, Inc., 
Andover, Massachusetts, USA), Paragon
® (Arthrocare, Inc.; 
Austin, Texas, USA), and Ceruleau
TM (NuOrtho Surgical, 
Inc., Fall River, Massachusetts, USA). Glider and Paragon 
deliver ablation-based radiofrequency energy through a 
monopolar and a bipolar mechanism, respectively, via direct 
electrode-to-tissue contact. Ceruleau delivers non-ablative 
radiofrequency energy through a bipolar mechanism initiated 
from a monopolar generator via a protected tip that prevents 
electrode-to-tissue contact. Of the three systems, Ceruleau is 
the only device designed with a mechanical feature for 
débridement chondroplasty via  the protective housing. 
Glider and Paragon allow mechanical débridement only by 
the use of the active electrode itself. Each system constituted 
one of the three treatment groups for each specimen with a 
fourth group serving as a control that did not receive any 
treatment. 
Treatment Sites
Specimen 
Sectioning 
Lines
Uniform Grade III
Cartilage Area
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  Each radiofrequency system was assigned its own station 
with an ex vivo arthroscopy set-up. Standard saline 
arthroscopic fluid was used at room temperature with a fluid-
flow rate of 30cc/min ± 5cc/min which created consistent 
fluid dynamics in the set-up typical of in vivo arthroscopy. 
The flow was measured and recorded at each station 
throughout the study and was maintained constant for all 
testing. The Glider and Paragon radiofrequency systems 
were used at the generator settings recommended by their 
manufacturer's design. Ceruleau was used at the generator 
setting determined to be most efficient for débridement 
chondroplasty even though the system has the ability to fine-
tune energy delivery level based upon patient-specific needs. 
  Débridement chondroplasty was performed by one 
practicing surgeon accustomed to radiofrequency 
débridement chondroplasty. The goal of the procedure was 
to remove the fibrillated and damaged cartilage and smooth 
the articular surface as determined by visual cues. Motorized 
shavers or other devices were not used. Energy delivery 
treatment time was 5 seconds for all specimens with a 
technique of moving the probe tip back and forth at the 
treatment site with a consistent application pressure and 
speed as judged by the surgeon to mimic in vivo treatment 
conditions [36]. With Glider and Paragon, the surgeon used 
the active electrode as a mechanical implement for gentle 
débridement, consistent with their design, by moving the 
electrode across the articular surface during the allotted 
energy deposition time. With Ceruleau, the surgeon used the 
protective housing to gently debride the fibrillated cartilage 
concurrent with energy delivery for the allotted treatment 
time. 
  Immediately after each treatment, three 0.5 mm coronal 
sections of each sample were obtained referencing the center 
of the treatment site. The sections were prepared for staining 
by washing in HEPES buffered saline solution. Live/Dead
® 
Reduced Biohazard Cell Viability Kit #1 “green and red 
fluorescence”, SKU #L-7013, (Invitrogen™, Carlsbad, 
California) was used per manufacturer’s specification to 
stain specimens. Specimens were gluteraldehyde fixed, 
transferred to standard flat glass slides, and flooded with 
VectaShield
® fluorescence protection oil prior to the 
placement of #1.5 borosilicate glass cover slips over each 
specimen section. 
  Confocal fluorescence laser microscopy analysis was 
performed by personnel blinded to the identity of the 
treatment groups for each specimen part. Confocal imaging 
was performed with an Olympus IX-81 inverted microscope 
coupled to an Olympus FV300 confocal laser scanning unit 
(Center Valley, Pennsylvania, USA) using 488 nm laser 
excitation. Live cells were captured under green fluorescent 
channel (505-525 nm) and dead cells were captured under 
red fluorescent channel (577-634 nm), generating a Live 
image, a Dead image, and an Integrated image. 
  The effectiveness of the débridement chondroplasty in 
removing fibrillated cartilage tissue and smoothing the 
Table 1.  The Three Radiofrequency Systems Studied 
 
Device Glider  Paragon-T2  Ceruleau 
Device Tip Design 
     
Active Electrode Configuration  Flat electrode; Direct Tissue Contact  Ring Electrode; Direct Tissue 
Contact 
Protected Electrode; Mechanical 
Housing 
RF Generator System  Vulcan-EAS 
Smith and Nephew 
Atlas 
Arthrocare 
Force FX-C 
Valley Lab 
Electrosurgical Design  Monopolar Bipolar  Bipolar operating from 
monopolar output 
Electrosurgical Mode  CUT CUT  COAG
4 
Power Output Settings  60 Watts  155-170 Watts  25 Watts 
Power Control  Manufacturer Preset 
Level 27 
Manufacturer Preset 
Level 6  Surgeon Controlled 
Approximate Electrode Surface 
Area Contacting Tissue 
1  0.9 mm
2 2.3  mm
2 Non-Contact 
Power Density at Tissue Surface 
2, 3  69 W/mm
2 67-73  W/mm
2 2.3  W/mm
2 
1Approximate surface area measurements of the Glider and Paragon active electrodes available for radiofrequency emittance. Both active electrodes are in direct contact with tissue 
and deposit energy deep into the tissue's substance. The Ceruleau electrode resides and performs its work within a protective electrically insulating housing that inhibits electrode-to-
tissue contact; therefore, the electrode surface area is not a significant factor at the tissue surface. 
2Power Density equals the power deployed through the exposed electrode surface area and reveals the power density required for direct-contact cartilage tissue ablation. The Glider 
and Paragon results are remarkably similar indicating a common threshold for inducing cartilage ablation, despite the differences in delivery modality between monopolar and 
bipolar, which demonstrates that the physical product design can offset energy delivery method. 
3A power density analysis of Ceruleau requires an area measurement of the openings in the protective housing and the distance of the electrode from the tissue surface. The power 
density at the tissue surface is approximately a 30 fold decrease from that of Glider and Paragon. Ceruleau operates at a higher nominal Voltage in COAG mode; therefore, the 
current density (the component of power density most responsible for ablation) at the tissue interface is further reduced from that of the ablation-based modalities. 
4Ceruleau is designed for use in a bipolar mode from a monopolar COAG output. These COAG waveforms are biased towards high peak-to-peak voltage levels in comparison to 
ablation-based systems with a higher current level bias. 214    The Open Orthopaedics Journal, 2010, Volume 4   et al. 
articular surface was assessed by gross visual inspection and 
microscopic imaging. The extent of collateral damage 
induced by each treatment was determined based upon both 
the amount of initially non-damaged cartilage tissue 
removed from the treatment site when compared to control 
specimens and the condition of the residual tissue remaining 
at the treatment site. Because of the difficulty in comparing 
fibrillation characteristics between patient sample groups, 
the amount of tissue removed was established by comparing 
cell density and chondrocyte characteristics of the cartilage's 
histologic zones relative to control specimens within each 
group as each zone contains a phenotypically distinct 
subpopulation of chondrocytes that differs in morphology 
and distribution within the matrix and chondron. Depth of 
necrosis of the residual tissue post-treatment was determined 
by measuring the distance from the center of the residual 
tissue surface after treatment to the lowest depth of dead 
cells observed. Multiple range ANOVA analysis was 
performed for depth of cartilage tissue necrosis and percent 
chondrocyte death for each device tested. 
RESULTS 
  Six patients yielding six separate specimens originating 
from femoral condyle resection were included for study, 
generating twenty-four osteochondral parts tested (n = 6 per 
Group; total sample parts = 24). All devices performed as 
suggested by manufacturer without device failure. The final 
surface morphologies were independently validated based 
upon visual and tactile cues by two surgeons as satisfactory 
clinical outcome of removing the fibrillated tissue. However, 
residual post-treatment tissue characteristics varied 
significantly between the treatment groups. Figs. (2-5) 
demonstrate representative images of the specimens for each 
group. 
  The control specimens (Fig. 2) demonstrate typical 
fibrillated articular surfaces consistent with gross visual 
inspection of the harvested tissues. The Superficial Zone was 
clearly disrupted by the fibrillation, but chondrocytes with a 
flattened chondron appearance typical of this zone remained 
present even toward the base of the fibrillation. In all control 
specimens, the fibrillation did not penetrate to the 
Transitional Zone of the cartilage tissue. Within the 
fibrillated tissue itself, live cells were observed residing 
within the tissue at varying distances from the surface of the 
fibrillation. Live cells were abundantly present in density 
patterns typical of healthy cartilage around and below the 
surface fibrillation. Cell population densities within each 
specimen group remained constant as the samples of each 
group originated from the same specimen. Inter-specimen 
comparisons did not reveal significant differences in relative 
cell population densities, chondron orientation, or cellular 
distribution patterns confirming similar lesion type included 
for study. Occasional dead cells were observed to reside in a 
more extruded position within the fibrillation itself but not 
within the substance of the morphologically intact cartilage 
tissue. Adjacent to the fibrillated segments, a more typical 
softened appearance was observed without fibrillation but 
with loss of surface cellularity and lacunar emptying within 
the Superficial Zone below the lamina splendens. 
  In the Glider treated samples (Fig. 3), large charred tissue 
segments and loss of cartilage thickness above that of control 
were observed throughout the treatment site. Tissue charring 
ranged from light-brownish color to near black or dark grey 
indicating severe char and tissue damage. There were areas 
of tissue fragmentation indicating ablation extraction of 
tissue as is typically observed during standard electrocautery 
procedures. No treated specimens yielded either a visually or 
histologically smooth cartilage surface even though the 
initial fibrillation of the specimens was eliminated. The 
fibrillated tissue surface was replaced with a residual layer of 
necrotic and damaged tissue in all instances. No specimen 
exhibited Superficial Zone characteristics due to the tissue 
loss that had occurred. Cellular density and chondrocyte 
characteristics of the residual tissue under the necrotic layer 
was markedly decreased and consistent with control 
specimen Transitional Zone cartilage depth, indicating 
significant loss of tissue exceeding the level of disease pre-
treatment. Dead cells were present under the charred surfaces 
in all specimens and occasionally intermixed with live cells. 
Due to the normally decreased cellular density of the 
Transitional Zone, the residual tissue under the charred layer 
exhibited dead cells in a widely distributed pattern within the 
cartilage matrix indicating significant penetration of the 
treatment through the extracellular matrix tissue and into 
deep chondrons. The mean post-treatment depth of necrosis 
of the remaining residual cartilage at the treatment site was 
 
Fig. (2). Confocal laser microscopy images, Control. Representative images depicting Live cell stain (green), Dead cell stain (red), and a 
combined image with both Live cell and Dead cell stain. Note the fibrillation within the Superficial Zone and the normal appearing elongated 
chondrocytes both within and around the fibrillation. Dead cells are observed only in extruded positions. Original magnification 10x. Radiofrequency Mediated Débridement Chondroplasty  The Open Orthopaedics Journal, 2010, Volume 4    215 
216.76  m (range 104.00 m - 333.79 m) through the 
Transitional Zone tissue (as distinct from necrosis through 
Superficial Zone tissue). 
  In the Paragon treated samples (Fig. 4), generalized 
gelatinization of tissue was observed at the treatment site 
indicative of altered matrix properties. The gelatinized tissue 
was observed to have a semi-translucent appearance and 
much softer consistency than the surrounding cartilage. 
Slightly less bulk loss of normal cartilage was observed 
when compared to the Glider specimens. In some areas, 
however, tissue charring in the same geometric pattern as 
that of the active electrode was visually noticeable in the 
treatment area. This observation was termed ablation 
electrode imprinting and was distinctly noticeable due to the 
unique ring shape of the Paragon electrode. A firmer 
consistency of the cartilage adjacent to the ablation electrode 
imprinting was noted with a more typical ablation tissue 
extraction pattern observed at the site of imprinting. All 
specimens yielded a surface elimination of the original 
fibrillated cartilage tissue and a resultant layer of post-
treatment necrotic tissue; and, all with some areas of ablation 
tissue extraction similar to the Glider samples and the goal of 
tissue ablation. The residual tissue exhibited some latent 
Superficial Zone characteristics such as elongated chondrons 
parallel to the articular surface. Abundant dead cells were 
intermixed with some live cells throughout the entire 
Superficial Zone in all specimens with additional dead cells 
observed into the superficial part of the Transitional Zone. 
The mean post-treatment depth of necrosis of the remaining 
cartilage at the treatment site was 149.46 m (range 115.00 
m - 201.29 m) which straddled the Superficial and 
Transitional Zones. 
  In the Ceruleau treated samples (Fig. 5), the fibrillated 
cartilage tissue was removed resulting in a smooth residual 
surface at the treatment site. No areas of charred, gelatinized, 
or color altered tissue were observed at the treatment site 
consistent with the non-ablative type of energy delivered. All 
specimens yielded a residual tissue bed demonstrating 
similar appearance and consistency to that of the non-
fibrillated tissue surrounding the treatment site. All 
specimens retained intact Superficial Zone characteristics in 
the residual tissue below the level of removed fibrillation 
without areas of necrosis or dead cells. Accordingly, no 
specimen part demonstrated additional bulk tissue loss other 
than that of the diseased fibrillated cartilage. Live cells were 
evident throughout the residual treatment site with 
chondrocytes residing closer to the surface than that noted in 
the non-fibrillated sections of the control specimens of each 
sample. This finding indicated an increased surface-based 
level of cellularity post-treatment in the retained Superficial 
Zone of the treatment site. 
  Multiple range ANOVA analysis demonstrated a 
statistically significant difference between the depth of 
cartilage tissue necrosis (p < 0.005) and percent chondrocyte 
death (p < 0.004) between the ablation (Glider and Paragon) 
and non-ablation (Ceruleau) devices, with no statistical 
difference between the two ablation (Glider and Paragon) 
devices tested. As depicted in Table 1, the power density 
levels delivered at the tissue surface by ablation-based 
devices exceed the energy thresholds that allow 
chondrocytes to survive. 
DISCUSSION 
  Many studies have supported the efficacy of débridement 
chondroplasty in relieving patient symptoms by smoothing 
the articular surface and decreasing the biologic load of joint 
cartilage debris [26-29]. Within the spectrum of cartilage 
lesions, the benefit of eliminating mechanical symptoms of 
cartilage disease is more apparent for traumatic focal lesions 
[28, 29]; whereas, the benefit of decreasing biologic load is 
generally more apparent for diffuse osteoarthritic cartilage 
lesions [26, 27]. Although intuitive that these benefits would 
contribute to long-term joint health, promotion of cartilage 
longevity and the mitigation of joint replacement surgery 
have not yet been clearly shown. Such long-term benefits are 
difficult to establish due to the large number of variables that 
need to be controlled, including type of cartilage lesion, 
concomitant joint pathology such as meniscus and ligament 
dysfunction, tissue senescence, genetic and inflammatory 
response variations, downstream mechanical experience, 
systemic health, and medical treatment history like intra-
articular corticosteroids, hyaluronic acid, and oral non-
steroidal anti-inflammatory use. 
  Notwithstanding noting such symptomatic improvement, 
researchers have questioned the efficacy of inducing damage 
to normal cartilage tissue during débridement chondroplasty 
whether by mechanical or ablation-based radiofrequency 
means [16-22], unless the mechanical symptoms of large 
chondral flaps are overwhelming. The issue of whether 
eliminating the symptoms from articular cartilage damage 
decreases the natural progression and/or disease burden is 
the subject of ongoing studies. If the natural progression of 
disease is slowed by débridement chondroplasty despite the 
current level of collateral damaged induced, this may justify 
the collateral damage caused by the treatments currently in 
use. If not, the benefits of symptom improvement may still 
be a worthwhile approach to disease burden based upon 
improving the feel and function of the joint, which can allow 
a more productive activity level for patients. 
  This study evaluated articular cartilage specimens 
demonstrating generalized surface fibrillation changes in 
patients undergoing joint replacement surgery. Although a 
small sample size, the results indicate that débridement 
chondroplasty can be performed for these lesions in a more 
precise manner than previously shown, preserving 
Superficial Zone characteristics, and without inducing 
necrosis or collateral damage at the treatment site when 
compared to ablation-based radiofrequency treatments. 
These results are obtained from a device which combines 
non-ablation radiofrequency energy delivery and gentle 
mechanical implement use, yielding an hybrid device 
bridging the efficacious aspects of the two main débridement 
chondroplasty techniques available today. Low-level 
energies are enabled by the protective housing that shields 
the active electrode from the convective forces of the 
treatment site (i.e. fluid flow during arthroscopy); whereas, 
ablation-based devices often need to increase their energy 
output to accommodate such forces because their electrodes 
are exposed and unprotected. 
  Ceruleau is part of a new group of radiofrequency 
devices that utilize non-ablative low-level radiofrequency 
energy that is delivered via a protected electrode geometry  
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which inhibits electrode-to-tissue contact. The protective 
housing can be optimally designed as a mechanical 
implement that functions as an adjunct to energy delivery 
while the active electrode can be optimally designed for low-
level energy delivery. Accordingly, the device provides a 
convenient method of tactile and visual feedback that is 
especially useful when modifying surface tissue morphology 
such as during débridement chondroplasty. Surgeons are able 
to employ the mechanical implement as a treatment lead to 
energy use allowing real-time visualization of the treated 
tissue during energy delivery. With ablation-based 
radiofrequency devices, the surgeon cannot see the tissue 
during energy delivery because of electrode-to-tissue contact 
requirements and can only receive visual cues once the 
 
Fig. (3). Confocal laser microscopy images, Glider. Representative images depicting Live cell stain (green), Dead cell stain (red), and a 
combined image with both Live cell and Dead cell stain. Note the level of tissue loss which brings the post-treatment residual necrotic 
cartilage layer into the Transitional Zone. The Transitional Zone typically demonstrates spherical chondrocytes of less dense population than 
the Superficial Zone. Original magnification 10x. 
 
Fig. (4). Confocal laser microscopy images, Paragon. Representative images depicting Live cell stain (green), Dead cell stain (red), and a 
combined image with both Live cell and Dead cell stain. Note that the Superficial Zone remains present, but with significant dead cells 
observed uniformly throughout this zone and into part of the Transitional Zone. Original magnification 10x. 
 
Fig. (5). Confocal laser microscopy images, Ceruleau. Representative images depicting Live cell stain (green), Dead cell stain (red), and a 
combined image with both Live cell and Dead cell stain. Note the decreased distance of live cells to the surface. These cells exhibit elongated 
morphology typical of the Superficial Zone. Dead cells are not observed in either the Superficial or Transitional Zone. Original magnification 
10x. 
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device is removed from the actual treatment site. For the 
ablation-based devices, the surgical technique used in this 
study of moving the ablation electrodes back and forth 
across the tissue simulates in vivo use conditions and likely 
is responsible for the lower depth of necrosis and intermixed 
live/dead cells observed in this study when compared to 
others which have demonstrated even more significant 
cartilage damage [16, 21, 30]. It remains, however, that an 
inadvertent pause in movement of ablation-based devices 
during use can cause ablation electrode imprinting, a subset 
of the more extensive tissue damage observed with these 
devices. Because electrode-to-tissue contact cannot occur 
with Ceruleau, electrode imprinting is not a tissue risk, 
allowing the surgeon a safer and more precise control of 
energy delivery. 
  The radiofrequency systems studied demonstrate 
different methods of delivering radiofrequency energy to 
tissues. Glider and Paragon deliver ablation-based energy. 
These cartilage ablation treatments are a necrosis-based 
intervention causing collateral damage via direct electrode-
to-tissue contact similar to cancer cell ablation and cardiac 
arrhythmia foci ablation during which the electrical work is 
performed within target tissue located well below the tissue 
surface. Since the intended goal of débridement 
chondroplasty is a tissue preserving surface modification, it 
remains counter-intuitive to use a technology designed for 
sub-surface tissue treatment like radiofrequency ablation for 
disease states demanding tissue preserving surface 
modification. This concern is especially valid for a tissue 
type like articular cartilage which retains high water content 
and therefore can efficiently pool electro-thermal energy to 
an effectively detrimental level. Ablation-based devices have 
been the subject of numerous studies quantifying the degree 
of cartilage necrosis, not the lack of cartilage necrosis [9-22, 
30, 31]. Consequently, cartilage researchers have looked for 
other additions to radiofrequency ablation energy delivery as 
mitigation for the effects caused by these devices [17, 32-34] 
since the residual tissue left behind at the treatment site is of 
poor quality, exhibiting significant tissue necrosis and 
collateral damage. This study further confirms the ablation-
based iatrogenic injury to articular cartilage that has been 
repeatedly noted by others and, more specifically, 
demonstrates significant injury to and loss of the Superficial 
Zone which has been strongly associated with the 
progression of cartilage disease [15, 35-39]. 
  Glider is an ablation-based monopolar system delivering 
radiofrequency energy directly to tissue much like that of 
standard electrocautery. The device tip design requires 
complete contact of the active electrode to the tissue during 
treatment, necessitating that the electrical current pass 
directly through the entire tissue thickness, creating damage 
which mimics electrical injury [40]. In this study, Glider 
eliminated the fibrillated cartilage of the lesions, but did not 
accomplish the goal of smoothing the articular surface. The 
treatment resulted in significant loss of normal cartilage 
tissue at the treatment site well below the level of original 
diseased tissue and into the initially intact Transitional Zone. 
The treatment replaced the fibrillated cartilage with a 
significant region of tissue loss and a resultant bed of 
necrotic cartilage. These results confirm other studies 
showing significant iatrogenic damage and loss of cartilage 
with monopolar ablation systems [10-12, 15, 16, 18, 19, 21, 
30, 31]. Despite this evidence, some have put forth the 
notion that the iatrogenic creation of charred, necrotic 
articular cartilage tissue is useful to protect the underlying 
undamaged cartilage from excess energy deposition which 
normally occurs during the treatment [41]. It would seem, 
however, that creating iatrogenic damage to protect against 
further iatrogenic damage is counterproductive to cartilage 
treatment efforts, especially when no clear benefit from the 
treatment has been demonstrated. In fact, it is likely that such 
treatment may accelerate the natural progression and disease 
burden of osteoarthritis [15, 19, 21, 22, 35, 39]. Since this 
study demonstrated live cells within and around the area of 
fibrillated cartilage in the control specimens as a baseline, 
the extent of tissue loss and corruption of the Superficial and 
Transitional Zones caused by this treatment approach 
remains detrimental to the preservation of healthy cartilage 
tissue. 
  Paragon is an ablation-based bipolar device that also 
delivers energy directly to tissue via  electrode-to-tissue 
contact. The device design requires significantly more power 
input to achieve the same amount of ablation energy delivery 
to the treatment site as that of Glider (Table 1). Consistent 
with other studies of bipolar energy delivery to articular 
cartilage [8, 9, 11, 14, 16, 18, 30], a distinct yet widespread 
geographic layer of necrosis and collateral damage was 
induced deep to the Transitional Zone. Significant cartilage 
loss was slightly less than that demonstrated with the Glider 
despite the much larger amount of energy required to effect 
bipolar cartilage ablation. This finding is partly due to the 
device design which requires high-level radiofrequency 
energy delivery to ablate tissue but allows the electrode to 
shunt high-level radiofrequency energy into the conductive 
media simultaneous with tissue ablation. Indeed, higher 
intra-articular fluid temperatures have been seen with 
ablation-based bipolar devices due to the high energy 
foundation required (i.e. plasma formation), a phenomenon 
which itself can lead to iatrogenic complications [34, 42, 43]. 
It remains unclear whether the gelatinization of cartilage at 
the treatment site observed in this study is limited to the area 
of induced chondrocyte necrosis in the Superficial and 
Transitional Zones or whether additional matrix or chondron 
collateral damage progresses deeper into the Transition Zone 
matrix as noted with Glider's monopolar energy delivery 
mechanism. 
  Ceruleau is a non-ablation bipolar device that is driven 
by a monopolar output which allows for a low-level and 
more precise amount of energy to be delivered to the 
treatment site. Since electrode-to-tissue contact cannot occur, 
Ceruleau delivers energy into the interfacing fluid medium 
within the protective housing. Therefore, the energy 
requirements for work are small as noted by the 25 Watts of 
energy deployed in this study to achieve a desirable 
outcome. The protective housing can be shaped to deliver 
this energy in a more precise manner than ablation-based 
devices which are dependent upon exposed tissue-contacting 
electrodes and are more subject to the varying conditions of 
the treatment site like arthroscopy fluid flow. Treatment 
energy requirements are further decreased since the system 
does not need to address impedance fluctuations originating 
from electrode-to-tissue contact which remains as a 
fundamental rationale for the high energy delivery 
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effect. For the surgeon, the low-level energy requirements of 
Ceruleau also translate to low bubble production which 
augments the ability to draw upon visual cues of the 
treatment site to control energy delivery. This study further 
demonstrates that ablation-based radiofrequency devices, 
because of their design, need to deliver much higher energy 
levels to articular cartilage than what is required for actual 
débridement chondroplasty. 
  The morphologic and histologic treatment results created 
by Ceruleau are vastly superior to those of other débridement 
chondroplasty techniques. The low-level energy delivery is 
configured to modify/precondition diseased cartilage  to a 
state amenable to a safe and effective gentle mechanical 
débridement.  The non-ablative energy affects the surface 
matrix structure of damaged cartilage tissue preferentially 
rather than the intact chondron and matrix tissue below the 
surface level as in ablation-based treatments. In this manner, 
the non-ablative energy takes advantage of the altered 
pericellular and extracellular matrices of diseased cartilage 
[44, 45] by preparing fibrillated tissue for débridement 
through augmented and/or naturally facile tissue cleavage 
patterns, creating a matrix-failure-based intervention. With 
the Ceruleau power wave shifted towards higher voltage 
levels rather than toward the higher current levels as required 
in ablation-based devices, the potential fields generated by 
Ceruleau allow beneficial electromagnetic affects as a 
precursor to additional tissue treatments. Others researchers 
have evaluated some aspects of non-contact ablation-level 
radiofrequency energy delivery to articular cartilage [16, 24, 
46-48], noting the validity of such approaches. Since 
Superficial Zone characteristics can be retained for the 
lesions examined in this study, it may be possible to address 
the natural progression of disease as an early surgical 
intervention, rather than contributing to the loss of 
functioning articular cartilage during débridement 
chondroplasty. Further studies are required to assess the 
significance of the surface changes of the Ceruleau post-
treatment specimens, particularly the increased density of 
live cells noted near the articular surface and within the 
Superficial Zone. 
  If iatrogenic cartilage damage can be eliminated during 
débridement chondroplasty, the procedure itself may be 
extended to other therapeutic interventions. With some 
ablation-based chondroplasty techniques, healing responses 
of the remaining cartilage have been observed [48, 49], 
indicating the possibility of in situ alteration of chondrocyte 
function in response to radiofrequency energy deposition. 
Dead chondrocytes at the treatment site as demonstrated with 
Glider and Paragon cannot be enrolled in additional 
therapeutic treatment efforts designed to augment tissue 
healing responses and will likely impair those efforts. If 
chondrocytes immediately surrounding the treatment site 
survive the precise removal of damaged tissue as observed in 
the Ceruleau treated specimens, the opportunity to effect 
beneficial changes in chondrocyte function remains whereby 
resident cell function may be recruited. For instance, 
chondrocyte transplantation procedures often fail due to 
impaired implant integration secondary to non-viable 
chondrocytes at the margins of the treatment defect [25, 50]. 
A more successful débridement chondroplasty or site 
preparation procedure may preserve chondrocyte 
differentiation potential evident in the Superficial and 
Transitional Zones [51] and may increase the chance of 
cellular-based integration. Preserving functioning Superficial 
Zone cartilage tissue will become even more important if the 
induction of chondrocyte healing responses becomes a 
standard treatment along with in situ cartilage repair or 
regeneration. Since ablation-based radiofrequency treatments 
significantly corrupt both the Superficial and Transitional 
Zones when present at the disease locale, precisely the zonal 
phenotypes that are deemed important for treatment of 
cartilage defects [51-55], and their use on articular cartilage 
should be further limited. 
CONCLUSION 
  The mechanism of radiofrequency energy deposition 
upon tissues is particularly important in treatment settings 
requiring tissue preservation. Systems that delivered 
ablation-based energies caused tissue necrosis and collateral 
damage at the treatment site including corruption of cartilage 
Superficial and Transitional Zones; whereas, the non-
ablation system created a smooth articular surface with 
Superficial Zone maintenance and without chondrocyte 
death or tissue necrosis. Ablation-based device systems can 
cause a worsened state of articular cartilage from that of pre-
treatment. Non-ablation energy can be successful in 
modifying/preconditioning tissue during débridement 
chondroplasty without causing collateral damage. Utilizing a 
non-ablation radiofrequency system provides the ability to 
perform successful débridement chondroplasty as an early 
surgical intervention for articular cartilage disease based 
upon matrix failure without causing additional articular 
cartilage tissue damage and may allow for other cartilage 
intervention success. 
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